Chronic hepatitis C, caused by the hepatitis C virus, can lead to severe complications such as liver cirrhosis and liver cancer. The advent of highly effective direct-acting antivirals (DAAs) has ...
Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, ...
Twenty-four weeks of bepirovirsen achieves a functional cure in approximately one-fifth of patients with chronic hepatitis B.
Weekly AHB-137 300 mg for 16 weeks achieved HBV DNA <10 IU/mL in 100% and complete response in 68% at end of treatment without concomitant nucleos(t)ide analogues. Baseline HBsAg stratified outcomes, ...
"HCC remains a major public health issue, disproportionately affecting minority populations and metropolitan US regions. Although multiple risk factors could also contribute to the mortality in ...
Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the lower limit of detection (LLOD), is associated with better clinical outcomes of ...
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the U.S. Food and Drug Administration (FDA) has cleared its investigational new drug (IND) application and ...
Chronic hepatitis delta virus (HDV) infection has its first FDA-approved treatment, after the agency granted accelerated approval to bulevirtide (Hepcludex) injection for adults without cirrhosis or ...
Five hepatitis viruses vary by transmission and prevention, but HBV and HCV account for the majority of global cirrhosis, hepatocellular carcinoma, and viral hepatitis-related deaths. Vaccination (HAV ...
Vaccination against hepatitis B is a common recommendation, but what exactly is it preventing? HHS Secretary Robert F. Kennedy Jr. and his advisory group plan to meet this week to discuss and vote on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results